These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8575864)

  • 21. Silicone breast implants: implications for society and surgeons.
    Renwick SB
    Med J Aust; 1996 Sep; 165(6):338-41. PubMed ID: 8862336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The silicone breast implant controversy.
    Guerette PH
    Can Nurse; 1995 Feb; 91(2):31-7. PubMed ID: 7780923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No FDA approval for silicone implants.
    Cockey CD
    AWHONN Lifelines; 2002 Dec; 6(6):496. PubMed ID: 12593250
    [No Abstract]   [Full Text] [Related]  

  • 24. Public health implications of differences in U.S. and European Union regulatory policies for breast implants.
    Zuckerman D; Booker N; Nagda S
    Reprod Health Matters; 2012 Dec; 20(40):102-11. PubMed ID: 23245415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Silicone gel-filled breast implants and breast cancer--an update and safety].
    Winkler E; Regev E; Bar-Meir E; Orenstein A
    Harefuah; 2004 Mar; 143(3):222-6, 244. PubMed ID: 15065364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of drugs and devices: an evolution.
    Merrill RA
    Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shattuck Lecture--evaluating the health risks of breast implants: the interplay of medical science, the law, and public opinion.
    Angell M
    N Engl J Med; 1996 Jun; 334(23):1513-8. PubMed ID: 8618607
    [No Abstract]   [Full Text] [Related]  

  • 29. Silicone breast implants: an oncologic perspective.
    Gerszten K; Gerszten PC
    Oncology (Williston Park); 1998 Oct; 12(10):1427-33; discussion 1434, 1439-43. PubMed ID: 9798198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying The Food And Drug Administration's rulemaking delays highlights the need for transparency.
    Hwang TJ; Avorn J; Carpenter D; Kesselheim AS
    Health Aff (Millwood); 2014 Feb; 33(2):309-15. PubMed ID: 24493775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The FDA process for the evaluation and approval of orthopaedic devices.
    Kirkpatrick JS; Stevens T
    J Am Acad Orthop Surg; 2008 May; 16(5):260-7. PubMed ID: 18460686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of transaxillary breast augmentation: lifetime probability of breast cancer development and sentinel node mapping interference.
    Prado A; Andrades P; Leniz P
    Aesthetic Plast Surg; 2007; 31(4):317-9. PubMed ID: 17549559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the safety of breast implants.
    Brody GS
    Plast Reconstr Surg; 1997 Oct; 100(5):1314-21. PubMed ID: 9326799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA & digital mammography: why has FDA required full field digital mammography systems to be regulated as potentially dangerous devices for more than 10 years?
    Nields MW
    Acad Radiol; 2010 May; 17(5):652-7. PubMed ID: 20380981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making a difference in the breast implant issue.
    McCain L
    Plast Surg Nurs; 1992; 12(1):28-30. PubMed ID: 1557454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
    Surprenant JA
    Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silicone breast implants not linked to breast cancer risk.
    Nelson NJ
    J Natl Cancer Inst; 2000 Nov; 92(21):1714-5. PubMed ID: 11058613
    [No Abstract]   [Full Text] [Related]  

  • 38. The new FDA combination products programme.
    Donawa M
    Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Silicone implants and breast cancer: real or fictitious problem? A case report and review of the literature].
    Daher M; Rizkallah P; Abdel-Hak E
    J Med Liban; 1994; 42(1):32-6. PubMed ID: 7629835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nine-Year Core Study Data for Sientra's FDA-Approved Round and Shaped Implants with High-Strength Cohesive Silicone Gel.
    Stevens WG; Calobrace MB; Harrington J; Alizadeh K; Zeidler KR; d'Incelli RC
    Aesthet Surg J; 2016 Apr; 36(4):404-16. PubMed ID: 26961987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.